S
IDYA icon

SignatureFD’s IDEAYA Biosciences IDYA Stock Holding History

SignatureFD’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177K Buy
4,746
+10
+0.2% +$306 ﹤0.01% 1162
2026
Q1 		$158K Buy
4,736
+117
+3% +$3.92K ﹤0.01% 1125
2025
Q4 		$160K Buy
4,619
+87
+2% +$2.77K ﹤0.01% 1087
2025
Q3 		$123K Sell
4,532
-17
-0.4% -$411 ﹤0.01% 1195
2025
Q2 		$95.6K Buy
4,549
+1,672
+58% +$32.1K ﹤0.01% 1252
2025
Q1 		$47.1K Buy
2,877
+2,271
+375% +$48.4K ﹤0.01% 1602
2024
Q4 		$15.6K Buy
606
+188
+45% +$5.32K ﹤0.01% 2187
2024
Q3 		$13.2K Sell
418
-31
-7% -$1.18K ﹤0.01% 2231
2024
Q2 		$15.8K Buy
449
+44
+11% +$1.74K ﹤0.01% 2077
2024
Q1 		$17.8K Hold
405
– – ﹤0.01% 2055
2023
Q4 		$14.4K Sell
405
-25
-6% -$746 ﹤0.01% 2088
2023
Q3 		$11.6K Hold
430
– – ﹤0.01% 2128
2023
Q2 		$10.1K Buy
430
+68
+19% +$1.4K ﹤0.01% 2232
2023
Q1 		$4.97K Sell
362
-111
-23% -$1.85K ﹤0.01% 2508
2022
Q4 		$8.59K Buy
473
+257
+119% +$4.32K ﹤0.01% 2223
2022
Q3 		$3K Buy
216
+135
+167% +$1.75K ﹤0.01% 2647
2022
Q2 		$1K Buy
+81
New +$901 ﹤0.01% 2928

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SignatureFD's IDYA Position: Q2 2026 in Review

SignatureFD increased its IDEAYA Biosciences (IDYA) stake by 0.21% in Q2 2026, buying an estimated $306 and bringing the position to 4,746 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #1162.

SignatureFD first reported a position in IDYA in Q2 2022 and has held it in 17 quarters since. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • SignatureFD held 4,746 shares of IDEAYA Biosciences worth $177K as of Q2 2026.
  • SignatureFD bought 10 IDEAYA Biosciences shares in Q2 2026, an estimated $306.
  • IDEAYA Biosciences made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1162 holding.
  • SignatureFD first reported a position in IDEAYA Biosciences in Q2 2022 and has held it in 17 quarters since.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.